{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:32:12Z","timestamp":1793928732341,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40123-020-00239-9","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T08:02:46Z","timestamp":1582790566000},"page":"235-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review"],"prefix":"10.1007","volume":"9","author":[{"given":"Giuseppe","family":"Giannaccare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Carnevali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Logozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Scorcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"239_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2174\/138920112800624355","volume":"13","author":"JL Alio","year":"2012","unstructured":"Alio JL, Arnalich-Montiel F, Rodriguez AE. The role of \u201ceye platelet rich plasma\u201d (E-PRP) for wound healing in ophthalmology. Curr Pharm Biotechnol. 2012;13:1257\u201365.","journal-title":"Curr Pharm Biotechnol"},{"key":"239_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","volume":"93","author":"RA Ralph","year":"1975","unstructured":"Ralph RA, Doane MG, Dohlman CH. Clinical experience with a mobile ocular perfusion pump. Arch Ophthalmol. 1975;93:1039\u201343.","journal-title":"Arch Ophthalmol"},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","volume":"56","author":"G Giannaccare","year":"2017","unstructured":"Giannaccare G, Versura P, Buzzi M, Primavera L, Pellegrini M, Campos EC. Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfus Apher Sci. 2017;56:595\u2013604.","journal-title":"Transfus Apher Sci"},{"key":"239_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1089\/jop.2012.0002","volume":"28","author":"KS Na","year":"2012","unstructured":"Na KS, Kim MS. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host diseases. J Ocul Pharmacol Ther. 2012;28:479\u201383.","journal-title":"J Ocul Pharmacol Ther"},{"key":"239_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","volume":"26","author":"CC Chiang","year":"2007","unstructured":"Chiang CC, Lin JM, Chen WL, Tsai YY. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea. 2007;26:861\u20133.","journal-title":"Cornea"},{"key":"239_CR6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/ICO.0000000000001257","volume":"36","author":"G Giannaccare","year":"2017","unstructured":"Giannaccare G, Buzzi M, Fresina M, Velati C, Versura P. Efficacy of 2-month treatment with cord blood serum eye drops in ocular surface disease: an in vivo confocal microscopy study. Cornea. 2017;36:915\u201321.","journal-title":"Cornea"},{"key":"239_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/bjophthalmol-2013-304801","volume":"99","author":"S Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay S, Sen S, Datta H. Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen\u2019s disease: a tear proteomic study. Br J Ophthalmol. 2015;99:108\u201312.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"239_CR8","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3892\/ijmm.2016.2532","volume":"37","author":"S Chung","year":"2016","unstructured":"Chung S, Rho S, Kim G, et al. Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury. Int J Mol Med. 2016;37(5):1170\u201380.","journal-title":"Int J Mol Med"},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41598-017-00298-2","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang W, Wang Y, Kong J, Dong M, Duan H, Chen S. Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy. Sci Rep. 2017;7:408.","journal-title":"Sci Rep"},{"key":"239_CR10","first-page":"405","volume":"36","author":"X Zhu","year":"2011","unstructured":"Zhu X, Jiang B, Zhang P, Zhou D. Effect of human umbilical cord blood stem cells on flash visual evoked potential in traumatic optic neuropathy in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011;36:405\u201311.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"239_CR11","doi-asserted-by":"publisher","first-page":"107699","DOI":"10.1016\/j.exer.2019.107699","volume":"185","author":"W Huang","year":"2019","unstructured":"Huang W, Wang C, Xie L, et al. Traditional two-dimensional mesenchymal stem cells (MSCs) are better than spheroid MSCs on promoting retinal ganglion cells survival and axon regeneration. Exp Eye Res. 2019;185:107699.","journal-title":"Exp Eye Res"},{"issue":"7","key":"239_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.4103\/1673-5374.160110","volume":"10","author":"ZJ Zhang","year":"2015","unstructured":"Zhang ZJ, Li YJ, Liu XG, et al. Human umbilical cord blood stem cells and brain-derived neurotrophic factor for optic nerve injury: a biomechanical evaluation. Neural Regen Res. 2015;10(7):1134\u20138.","journal-title":"Neural Regen Res"},{"issue":"4","key":"239_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4103\/1673-5374.180753","volume":"11","author":"XM Lv","year":"2016","unstructured":"Lv XM, Liu Y, Wu F, Yuan Y, Luo M. Human umbilical cord blood-derived stem cells and brain-derived neurotrophic factor protect injured optic nerve: viscoelasticity characterization. Neural Regen Res. 2016;11(4):652\u20136.","journal-title":"Neural Regen Res"},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/scd.2014.0255","volume":"24","author":"C Shao","year":"2015","unstructured":"Shao C, Chen J, Chen P, et al. Targeted transplantation of human umbilical cord blood endothelial progenitor cells with immunomagnetic nanoparticles to repair corneal endothelium defect. Stem Cells Dev. 2015;24:756\u201367.","journal-title":"Stem Cells Dev"},{"key":"239_CR15","doi-asserted-by":"publisher","first-page":"e69938","DOI":"10.1371\/journal.pone.0069938","volume":"8","author":"B Jiang","year":"2013","unstructured":"Jiang B, Zhang P, Zhou D, Zhang J, Xu X, Tang L. Intravitreal transplantation of human umbilical cord blood stem cells protects rats from traumatic optic neuropathy. PLoS One. 2013;8:e69938.","journal-title":"PLoS One"},{"key":"239_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainres.2013.07.037","volume":"1532","author":"M Chen","year":"2013","unstructured":"Chen M, Xiang Z, Cai J. The anti-apoptotic and neuro-protective effects of human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) on acute optic nerve injury is transient. Brain Res. 2013;1532:63\u201375.","journal-title":"Brain Res"},{"key":"239_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00417-011-1635-7","volume":"249","author":"T Zhao","year":"2011","unstructured":"Zhao T, Li Y, Tang L, Li Y, Fan F, Jiang B. Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats. Graefes Arch Clin Exp Ophthalmol. 2011;249:1021\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"239_CR18","first-page":"87","volume":"2010","author":"MC Pasquini","year":"2010","unstructured":"Pasquini MC, Wang Z, Horowitz MM, Gale RP. 2010 Report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl. 2010;2010:87\u2013105.","journal-title":"Clin Transpl"},{"key":"239_CR19","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1523\/JNEUROSCI.1532-17.2018","volume":"38","author":"S Koh","year":"2018","unstructured":"Koh S, Chen WJ, Dejneka NS, et al. Subretinal human umbilical tissue-derived cell transplantation preserves retinal synaptic connectivity and attenuates M\u00fcller glial reactivity. J Neurosci. 2018;38:2923\u201343.","journal-title":"J Neurosci"},{"key":"239_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/sctm.17-0187","volume":"7","author":"E Reid","year":"2018","unstructured":"Reid E, Guduric-Fuchs J, O\u2019Neill CL, et al. Preclinical evaluation and optimization of a cell therapy using human cord blood-derived endothelial colony-forming cells for ischemic retinopathies. Stem Cells Transl Med. 2018;7:59\u201367.","journal-title":"Stem Cells Transl Med"},{"key":"239_CR21","first-page":"559","volume":"11","author":"GH He","year":"2018","unstructured":"He GH, Zhang W, Ma YX, et al. Mesenchymal stem cells-derived exosomes ameliorate blue light stimulation in retinal pigment epithelium cells and retinal laser injury by VEGF-dependent mechanism. Int J Ophthalmol. 2018;11:559\u201366.","journal-title":"Int J Ophthalmol"},{"key":"239_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/iub.1608","volume":"69","author":"EM Mohamed","year":"2017","unstructured":"Mohamed EM, Abdelrahman SA, Hussein S, Shelaby SM, Mosaad H, Awad AM. Effect of human umbilical cord blood mesenchymal stem cells administered by intravenous or intravitreal routes on cryo-induced retinal injury. IUBMB Life. 2017;69:188\u2013201.","journal-title":"IUBMB Life"},{"key":"239_CR23","first-page":"53","volume":"53","author":"M Dong","year":"2017","unstructured":"Dong M, Zhang W, Chen S, et al. The protective effect of human umbilical cord mesenchymal stem cells-induced neural stem cells in the vitreous on the blood-retinal barrier in diabetic rats. Zhonghua Yan Ke Za Zhi. 2017;53:53\u20138.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"239_CR24","first-page":"1578","volume":"9","author":"D Wang","year":"2016","unstructured":"Wang D, Zhang B, Shi H, et al. Effect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation. J Ophthalmol. 2016;9:1578\u201383.","journal-title":"J Ophthalmol"},{"key":"239_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1080\/02713683.2018.1440604","volume":"43","author":"S Ji","year":"2018","unstructured":"Ji S, Lin S, Chen J, et al. Neuroprotection of transplanting human umbilical cord mesenchymal stem cells in a microbead induced ocular hypertension rat model. Curr Eye Res. 2018;43:810\u201320.","journal-title":"Curr Eye Res"},{"key":"239_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/01.ico.0000183484.85636.b6","volume":"25","author":"KC Yoon","year":"2006","unstructured":"Yoon KC, Im SK, Park YG, Jung YD, Yang SY, Choi J. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea. 2006;25:268\u201372.","journal-title":"Cornea"},{"key":"239_CR27","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","volume":"114","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, You IC, Im SK, Jeong TS, Park YG, Choi J. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology. 2007;114:1637\u201342.","journal-title":"Ophthalmology"},{"key":"239_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","volume":"144","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144:86\u201392.","journal-title":"Am J Ophthalmol"},{"key":"239_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3341\/kjo.2005.19.3.174","volume":"19","author":"KC Yoon","year":"2005","unstructured":"Yoon KC, Heo H, Jeong IY, Park YG. Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect. Korean J Ophthalmol. 2005;19:174\u20138.","journal-title":"Korean J Ophthalmol"},{"key":"239_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.bmt.1705566","volume":"39","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, Jeong IY, Im SK, Park YG, Kim HJ, Choi J. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transpl. 2007;39:231\u20135.","journal-title":"Bone Marrow Transpl"},{"key":"239_CR31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/ICO.0b013e31820d850f","volume":"30","author":"KC Yoon","year":"2011","unstructured":"Yoon KC, Choi W, You IC, Choi J. Application of umbilical cord serum eyedrops for recurrent corneal erosions. Cornea. 2011;30:744\u20138.","journal-title":"Cornea"},{"issue":"1","key":"239_CR32","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1111\/j.1755-3768.2012.02538.x","volume":"91","author":"KC Yoon","year":"2013","unstructured":"Yoon KC, Oh HJ, Park JW, Choi J. Application of umbilical cord serum eyedrops after laser epithelial keratomileusis. Acta Ophthalmol. 2013;91(1):e22\u20138.","journal-title":"Acta Ophthalmol"},{"key":"239_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4068\/cmj.2014.50.3.82","volume":"50","author":"KC Yoon","year":"2014","unstructured":"Yoon KC. Use of umbilical cord serum in ophthalmology. Chonnam Med J. 2014;50:82\u20135.","journal-title":"Chonnam Med J."},{"issue":"4","key":"239_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/15569527.2019.1573244","volume":"38","author":"KE Han","year":"2019","unstructured":"Han KE, Park MH, Kong KH, Choi E, Choi KR, Jun RM. Therapeutic effects of three human-derived materials in a mouse corneal alkali burn model. Cutan Ocul Toxicol. 2019;38(4):315\u201321.","journal-title":"Cutan Ocul Toxicol"},{"key":"239_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3109\/02713683.2012.717243","volume":"37","author":"HJ Oh","year":"2012","unstructured":"Oh HJ, Jang JY, Li Z, Park SH, Yoon KC. Effects of umbilical cord serum eye drops in a mouse model of ocular chemical burn. Curr Eye Res. 2012;37:1084\u201390.","journal-title":"Curr Eye Res"},{"key":"239_CR36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/ICO.0000000000000747","volume":"35","author":"G Giannaccare","year":"2016","unstructured":"Giannaccare G, Bonifazi F, Sessa M, et al. Dry eye is already present in hematological patients before hematopoietic stem cell transplantation. Cornea. 2016;35:638\u201343.","journal-title":"Cornea"},{"key":"239_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/IMCRJ.S89968","volume":"8","author":"G Giannaccare","year":"2015","unstructured":"Giannaccare G, Fresina M, Vagge A, Versura P. Synergistic effect of regenerating agent plus cord blood serum eye drops for the treatment of resistant neurotrophic keratitis: a case report and a hypothesis for pathophysiologic mechanism. Int Med Case Rep J. 2015;8:277\u201381.","journal-title":"Int Med Case Rep J"},{"key":"239_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/EB.S117261","volume":"10","author":"P Versura","year":"2018","unstructured":"Versura P, Giannaccare G, Pellegrini M, Sebastiani S, Campos E. Neurotrophic keratitis: current challenges and future prospects. Eye Brain. 2018;10:37\u201345.","journal-title":"Eye Brain"},{"key":"239_CR39","doi-asserted-by":"crossref","unstructured":"Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 2003;87(11):1312\u20136.","DOI":"10.1136\/bjo.87.11.1312"},{"key":"239_CR40","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1167\/iovs.09-4170","volume":"52","author":"N Sharma","year":"2011","unstructured":"Sharma N, Goel M, Velpandian T, Titiyal JS, Tandon R, Vajpayee RB. Evaluation of umbilical cord serum therapy in acute ocular chemical burns. Investig Ophthalmol Vis Sci. 2011;52:1087\u201392.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"239_CR41","first-page":"807","volume":"7","author":"E Erdem","year":"2014","unstructured":"Erdem E, Yagmur M, Harbiyeli I, Taylan-Sekeroglu H, Ersoz R. Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects. Int J Ophthalmol. 2014;7:807\u201310.","journal-title":"Int J Ophthalmol"},{"key":"239_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/ICO.0b013e3182580762","volume":"32","author":"P Versura","year":"2013","unstructured":"Versura P, Profazio V, Buzzi M, et al. Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. Cornea. 2013;32:412\u20138.","journal-title":"Cornea"},{"issue":"5","key":"239_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/ICL.0000000000000277","volume":"43","author":"N Kamble","year":"2017","unstructured":"Kamble N, Sharma N, Maharana PK, et al. Evaluation of the role of umbilical cord serum and autologous serum therapy in reepithelialization after keratoplasty: a randomized controlled clinical trial. Eye Contact Lens. 2017;43(5):324\u20139.","journal-title":"Eye Contact Lens"},{"key":"239_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314859","author":"E Campos","year":"2019","unstructured":"Campos E, Versura P, Buzzi M, et al. Blood derived treatment from two allogeneic sources for severe dry eye associated to keratopathy: a multicentre randomised cross over clinical trial. Br J Ophthalmol. 2019. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314859.","journal-title":"Br J Ophthalmol"},{"key":"239_CR45","first-page":"2381296","volume":"2018","author":"E Campos","year":"2018","unstructured":"Campos E, Versura P, Giannaccare G, et al. Topical treatment with cord blood serum in glaucoma patients: a preliminary report. Case Rep Ophthalmol Med. 2018;2018:2381296.","journal-title":"Case Rep Ophthalmol Med"},{"key":"239_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2018.02.009","volume":"189","author":"TK Ali","year":"2018","unstructured":"Ali TK, Gibbons A, Cartes C, et al. Use of autologous serum tears for the treatment of ocular surface disease from patients with systemic autoimmune diseases. Am J Ophthalmol. 2018;189:65\u201370.","journal-title":"Am J Ophthalmol"},{"key":"239_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/tjo.tjo_102_17","volume":"7","author":"IH Ma","year":"2017","unstructured":"Ma IH, Chen LW, Tu WH, Lu CJ, Huang CJ, Chen WL. Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome. Taiwan J Ophthalmol. 2017;7:213\u201320.","journal-title":"Taiwan J Ophthalmol"},{"key":"239_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12882-018-1127-7","volume":"19","author":"MJ Damasiewicz","year":"2018","unstructured":"Damasiewicz MJ, Lu ZX, Kerr PG, Polkinghorne KR. The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort. BMC Nephrol. 2018;19:325.","journal-title":"BMC Nephrol"},{"key":"239_CR49","first-page":"508","volume":"24","author":"B Dziankowska-Bartkowiak","year":"2006","unstructured":"Dziankowska-Bartkowiak B, Waszczykowska E, Dziankowska-Zaboroszczyk E, et al. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis\u2014association with pulmonary involvement. Clin Exp Rheumatol. 2006;24:508\u201313.","journal-title":"Clin Exp Rheumatol"},{"key":"239_CR50","first-page":"145","volume":"14","author":"P Versura","year":"2016","unstructured":"Versura P, Buzzi M, Giannaccare G, et al. Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops. Blood Transfus. 2016;14:145\u201351.","journal-title":"Blood Transfus"},{"issue":"9","key":"239_CR51","doi-asserted-by":"publisher","first-page":"E1478","DOI":"10.3390\/jcm8091478","volume":"8","author":"F Bernabei","year":"2019","unstructured":"Bernabei F, Roda M, Buzzi M, Pellegrini M, Giannaccare G, Versura P. Blood-based treatments for severe dry eye disease: the need of a consensus. J Clin Med. 2019;8(9):E1478. https:\/\/doi.org\/10.3390\/jcm8091478.","journal-title":"J Clin Med"},{"key":"239_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4252\/wjsc.v6.i2.111","volume":"6","author":"TK Ng","year":"2014","unstructured":"Ng TK, Fortino VR, Pelaez D, Cheung HS. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J Stem Cells. 2014;6:111\u20139.","journal-title":"World J Stem Cells"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00239-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-020-00239-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00239-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T15:14:05Z","timestamp":1652109245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-020-00239-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1007\/s40123-020-00239-9","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"14 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The license text was incorrectly structured. The article has been corrected.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}